Searched for
SUN PHARMA COO
From pills to powerplays: Sun Pharma joins RCB as principal sponsor for IPL 2026Sun Pharmaceutical Industries enters cricket sponsorship for the first time. They have partnered with Royal Challengers Bengaluru for three...- Sun Pharmaceutical says it won't expand US manufacturing base amid tariff concernsSun Pharmaceutical, India's largest drug maker, is not planning to expand its manufacturing base in the US, citing sufficient existing capa...
- Sun Pharma elevates Aalok Shanghvi as COOSun Pharma, India's largest drugmaker, has designated Aalok Shanghvi as Chief Operating Officer. Aalok, the son of promoter Dilip Shanghvi,...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Ami Lifesciences appoints Amit Kaptain as CEOAs part of the Ami Lifesciences senior management team, Kaptain will be responsible for building business strategy and longstanding global ...
- Why a new expat CEO may be good news for Dr Reddy’sDrug maker undergoing major changes under Erez Islraeli
- Why Indian pharma needs more expats on boardsExpats at the helm can help improve corporate governance and transparency
- As going gets tough, pharma firms revisit past decisionsCompanies have rationalised field force and restructured product portfolio to up productivity.
- At the helm at Dr. Reddy's, Erez Israeli will have his task cut outIsraeli will replace Abhijit Mukherjee, who retires following his 15-year stint at the company. Mukherjee's tenure as COO was marked with u...
- How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the USWhile the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...
- Aurobindo Pharma appoints former Ranbaxy senior executive Sanjeev Dani as COOAurobindo Pharma has appointed Sanjeev Dani, former senior executive with Ranbaxy Laboratories, as chief operating officer and head of form...
- Cipla only Indian firm in race for Kremers UrbanIf Cipla is able to close it, the deal, pegged at around $1.3 billion, will eclipse Lupin’s recent $880 million buyout of Gavis Pharma.
- Markets may have negative bias, but steep fall unlikely: Ashu Madan, Religare SecuritiesMadan is recommending IDFC and is expecting the stock to see levels of Rs 250-300. He believes one should buy the stock on every dip.
- Drug pricing policy: IPA agrees to PMEAC's hybrid formulaIn its presentation to the Group of Ministers (GoM) on drug pricing on Monday, the industry body adopted a more flexible position.
- Buy Sun Pharma on decline: Ambareesh Baliga, Way2Wealth BrokersSun Pharma has corrected decently today, so today also there is an opportunity to pick up Sun Pharma at lower levels.
- Positive on Sun Pharma: Ambareesh BaligaThis stock can still move up to those levels of 470-480 but may not be in this move but surely over the next month, month-and-a-half.
- Ranbaxy to hive off R&D bizRanbaxy Laboratories is planning to hive off the research and development (R&D) of its new chemical entities (NCEs) into a separate company.
- Dr Reddy's in race for US Par PharmaDr Reddy’s Laboratories is in the race with three other Indian drug majors to acquire US-based generic drug maker Par Pharma.
- Ranbaxy to enter US anti-cancer segmentIn line with the company’s strategy to focus on speciality drugs in the US, drug major Ranbaxy is set to foray into the anti-cancer drug ma...
- Local pharma eyes layers of US skincare marketThe skincare segment in the US has caught the fancy of Indian drug makers who are looking at the inorganic route to consolidate their prese...
Load More
